We’re refreshing!

Come experience the new website and submit your feedback. The current site will temporarily
remain available as we make the final adjustments to the new online experience.

Click here to check it out. ►
1 888 2 DONATE(1 888 236-6283)
Find a Clinic:  search Search this site:  search
Book an appointment
Home > What Should I Know? > vCJD
Facebook youTube Twitter flickr
Why Should I Donate?
Who Needs Blood?
Can I donate?
Basic Eligibility
Donor Questionnaire
Malaria policy
Donation Date Calculator
American Sign Language
What Can I Donate?
Types of Donations
Plasma & Platelets
Stem Cells
Financial Gifts
Blood for Research
How Can I Get Involved?
In My Community
Send an e-card
Public Involvement
Partners for Life
What's Your Type
Sign Up to Learn More
Young Blood For Life
Assignment Saving Lives
National Blood Donor Week
What Should I Know?
Pandemic Preparedness
Safety and Testing
Research & Development
West Nile Virus (WNV)
Transfusion Related Acute Lung Injury (TRALI)
vCJD Travel Deferral
Become a Volunteer
New Donor Form
Change Your Address
Join OneMatch
Become a Partner for Life Organization
Become a Partner for Life Member
Join Ready, Set... Give!
Donor Experience Survey
Customer Service
Circular of Information
Customer Letters
Plasma Protein Products
Hospital Customer Forms
Resource Library
OneMatch Documents
Adverse Events
Diagnostic Services

vCJD Travel Deferral

Variant Creutzfeldt Jakob Disease (vCJD) is a neurodegenerative disease that occurs in people with a mean age under 30.

Deferral Policies for vCJD

The Canadian Blood Services deferral policy for vCJD is the following:

People are not eligible to donate blood or plasma if they have spent a cumulative total of three months or more in the United Kingdom (U.K.) between 1980, and 1996, or if they have spent a cumulative total of three months or more in France between 1980, and 1996, or if they have spent a cumulative total of five years or more in Western Europe outside the U.K. or France since 1980. In addition, people are not eligible to donate blood or plasma if they have had a blood transfusion or have received medical treatment with a product made from blood in the U.K., France or Western Europe since 1980.

Western Europe includes:

Belgium, Luxembourg, Spain, Germany, Italy, Switzerland, Republic of Ireland, Netherlands, Austria, Liechtenstien, Portugal, Denmark

The U.K. includes:

England, Northern Ireland, Scotland, Isle of Man, Wales, Channel Islands

Why was this policy introduced?

This policy was introduced to address concerns regarding variant Creutzfeldt-Jakob Disease (variant CJD). Variant CJD is sometimes called the human equivalent of “mad cow” disease.

Annual Review of Policy

When the vCJD deferral policy was introduced in 1999, Canadian Blood Services said it would review it annually in consultation with Health Canada and Héma-Québec, and potentially revise it as appropriate.

Canadian Blood Services introduced its first deferral policy for vCJD in 1999, and announced that people could no longer donate blood if they had spent six months or more in the U.K. since 1980.

The vCJD deferral policy was expanded in 2000 to include people who had spent six months or more in France since 1980.

The vCJD deferral policy was further revised in 2001.

The vCJD deferral policy was further revised in August 2005.

If you think this policy may apply to you, please do not decide on your own to stop donating blood or plasma. You should contact the staff at your nearest Canadian Blood Services location or call 1 888 2 DONATE.

vCJD Travel Deferral
Classical CJD- vCJD
vCJD Symptoms
Creutzfeldt Jakob Disease - FAQ

Top of the page Privacy and Access to Information | Terms of Use | Copyright © 1998-2015 Canadian Blood Services. All rights reserved.